Foghorn Therapeutics
Massachusetts, United States
101-250 Employees
Healthcare
•Tech
Director, DMPK
Massachusetts, --
Full time
Description
Foghorn Therapeutics is a biotechnology company focused on discovering and developing novel therapeutics targeting chromatin dysregulation to treat cancer and other diseases. Founded in [year], Foghorn Therapeutics is dedicated to leveraging its unique insights into chromatin biology to create innovative therapies that have the potential to transform patient care.
Financials
Type
public
Annual Revenue
--
Market Cap
$234.7M+
Subscribe to Refer Me premium to get referred to this role at Foghorn Therapeutics!
